Bluejay Diagnostics, Inc. 8-K

What Happened

• On May 27, 2026, Bluejay Diagnostics, Inc. (Bluejay) entered into an agreement and statement of work with Argonaut Manufacturing Services c/o Argonaut, Inc. to provide manufacturing services supporting Bluejay’s Symphony™ platform for IL-6 testing products.
• The company disclosed the arrangement in a Form 8-K filed June 2, 2026, and issued a related press release the same day. The agreement text is filed as Exhibit 10.1 to the 8-K.

Key Details

• Counterparty: Argonaut Manufacturing Services (c/o Argonaut, Inc.).
• Effective date of agreement: May 27, 2026; Form 8-K filed June 2, 2026.
• Scope of services: planning, engineering, sourcing, supply chain management, formulation, filling, finishing, quality control testing, procurement of capital equipment, product storage, delivery and distribution for IL-6 testing products.
• Execution: Services will be performed pursuant to purchase orders issued by Bluejay to Argonaut; no financial terms or volumes were disclosed in the 8-K. The press release is filed as Exhibit 99.1.

Why It Matters

• This agreement establishes an external manufacturing partner to support production of Bluejay’s Symphony IL-6 tests, a key operational step toward scaling manufacturing and distribution.
• The 8-K does not disclose pricing, minimum volumes, or financial commitments, so investors should note that the commercial and financial impact will depend on future purchase orders and additional disclosures.
• Watch for follow-up filings or updates (e.g., purchase orders, financial guidance, supply milestones) that would clarify timing, costs, and expected revenue impact.